Global Active Pharmaceutical Ingredient Market Outlook 2021

1 Active Pharmaceutical Ingredient Market Overview

• 1.1 Product Overview and Scope of Active Pharmaceutical Ingredient
• 1.2 Active Pharmaceutical Ingredient Segment by Type
  • 1.2.1 Global Active Pharmaceutical Ingredient Sales Growth Rate Comparison by Type (2020-2026)
  • 1.2.2 Synthetic API
  • 1.2.3 Biotech API
  • 1.2.4 Other
• 1.3 Active Pharmaceutical Ingredient Segment by Application
  • 1.3.1 Active Pharmaceutical Ingredient Sales Comparison by Application: (2020-2026)
  • 1.3.2 Chemical
  • 1.3.3 Deodorant
  • 1.3.4 Dailylife
• 1.4 Global Active Pharmaceutical Ingredient Market Size Estimates and Forecasts
  • 1.4.1 Global Active Pharmaceutical Ingredient Revenue 2015-2026
  • 1.4.2 Global Active Pharmaceutical Ingredient Sales 2015-2026
  • 1.4.3 Active Pharmaceutical Ingredient Market Size by Region: 2020 Versus 2026

2 Global Active Pharmaceutical Ingredient Market Competition by Manufacturers

• 2.1 Global Active Pharmaceutical Ingredient Sales Market Share by Manufacturers (2015-2020)
• 2.2 Global Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2015-2020)
• 2.3 Global Active Pharmaceutical Ingredient Average Price by Manufacturers (2015-2020)
• 2.4 Manufacturers Active Pharmaceutical Ingredient Manufacturing Sites, Area Served, Product Type
• 2.5 Active Pharmaceutical Ingredient Market Competitive Situation and Trends
  • 2.5.1 Active Pharmaceutical Ingredient Market Concentration Rate
  • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
• 2.7 Primary Interviews with Key Active Pharmaceutical Ingredient Players (Opinion Leaders)

3 Active Pharmaceutical Ingredient Retrospective Market Scenario by Region

• 3.1 Global Active Pharmaceutical Ingredient Retrospective Market Scenario in Sales by Region: 2015-2020
• 3.2 Global Active Pharmaceutical Ingredient Retrospective Market Scenario in Revenue by Region: 2015-2020
• 3.3 North America Active Pharmaceutical Ingredient Market Facts & Figures by Country
  • 3.3.1 North America Active Pharmaceutical Ingredient Sales by Country
  • 3.3.2 North America Active Pharmaceutical Ingredient Sales by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Active Pharmaceutical Ingredient Market Facts & Figures by Country
  • 3.4.1 Europe Active Pharmaceutical Ingredient Sales by Country
  • 3.4.2 Europe Active Pharmaceutical Ingredient Sales by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Active Pharmaceutical Ingredient Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Active Pharmaceutical Ingredient Sales by Region
  • 3.5.2 Asia Pacific Active Pharmaceutical Ingredient Sales by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Active Pharmaceutical Ingredient Market Facts & Figures by Country
  • 3.6.1 Latin America Active Pharmaceutical Ingredient Sales by Country
  • 3.6.2 Latin America Active Pharmaceutical Ingredient Sales by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Active Pharmaceutical Ingredient Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Active Pharmaceutical Ingredient Sales by Country
  • 3.7.2 Middle East and Africa Active Pharmaceutical Ingredient Sales by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Active Pharmaceutical Ingredient Historic Market Analysis by Type

• 4.1 Global Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
• 4.2 Global Active Pharmaceutical Ingredient Revenue Market Share by Type (2015-2020)
• 4.3 Global Active Pharmaceutical Ingredient Price Market Share by Type (2015-2020)
• 4.4 Global Active Pharmaceutical Ingredient Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Active Pharmaceutical Ingredient Historic Market Analysis by Application

• 5.1 Global Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
• 5.2 Global Active Pharmaceutical Ingredient Revenue Market Share by Application (2015-2020)
• 5.3 Global Active Pharmaceutical Ingredient Price by Application (2015-2020)

6 Company Profiles and Key Figures in Active Pharmaceutical Ingredient Business

• 6.1 Teva
  • 6.1.1 Corporation Information
  • 6.1.2 Teva Description, Business Overview
  • 6.1.3 Teva Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
  • 6.1.4 Teva Products Offered
  • 6.1.5 Teva Recent Development
• 6.2 Novartis
  • 6.2.1 Novartis Corporation Information
  • 6.2.2 Novartis Description, Business Overview
  • 6.2.3 Novartis Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
  • 6.2.4 Novartis Products Offered
  • 6.2.5 Novartis Recent Development
• 6.3 Pfizer
  • 6.3.1 Pfizer Corporation Information
  • 6.3.2 Pfizer Description, Business Overview
  • 6.3.3 Pfizer Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
  • 6.3.4 Pfizer Products Offered
  • 6.3.5 Pfizer Recent Development
• 6.4 Johnson & Johnson
  • 6.4.1 Johnson & Johnson Corporation Information
  • 6.4.2 Johnson & Johnson Description, Business Overview
  • 6.4.3 Johnson & Johnson Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Johnson & Johnson Products Offered
  • 6.4.5 Johnson & Johnson Recent Development
• 6.5 Mylan
  • 6.5.1 Mylan Corporation Information
  • 6.5.2 Mylan Description, Business Overview
  • 6.5.3 Mylan Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
  • 6.5.4 Mylan Products Offered
  • 6.5.5 Mylan Recent Development
• 6.6 North China Pharmaceutical Group
  • 6.6.1 North China Pharmaceutical Group Corporation Information
  • 6.6.2 North China Pharmaceutical Group Description, Business Overview
  • 6.6.3 North China Pharmaceutical Group Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
  • 6.6.4 North China Pharmaceutical Group Products Offered
  • 6.6.5 North China Pharmaceutical Group Recent Development
• 6.7 Dr. Reddy’s Laboratories
  • 6.6.1 Dr. Reddy’s Laboratories Corporation Information
  • 6.6.2 Dr. Reddy’s Laboratories Description, Business Overview
  • 6.6.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Dr. Reddy’s Laboratories Products Offered
  • 6.7.5 Dr. Reddy’s Laboratories Recent Development
• 6.8 Roche
  • 6.8.1 Roche Corporation Information
  • 6.8.2 Roche Description, Business Overview
  • 6.8.3 Roche Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
  • 6.8.4 Roche Products Offered
  • 6.8.5 Roche Recent Development
• 6.9 Aurobindo pharma
  • 6.9.1 Aurobindo pharma Corporation Information
  • 6.9.2 Aurobindo pharma Description, Business Overview
  • 6.9.3 Aurobindo pharma Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
  • 6.9.4 Aurobindo pharma Products Offered
  • 6.9.5 Aurobindo pharma Recent Development
• 6.10 Sun Pharmaceutical Industries
  • 6.10.1 Sun Pharmaceutical Industries Corporation Information
  • 6.10.2 Sun Pharmaceutical Industries Description, Business Overview
  • 6.10.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
  • 6.10.4 Sun Pharmaceutical Industries Products Offered
  • 6.10.5 Sun Pharmaceutical Industries Recent Development
• 6.11 Boehringer Ingelheim GmbH
  • 6.11.1 Boehringer Ingelheim GmbH Corporation Information
  • 6.11.2 Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Description, Business Overview
  • 6.11.3 Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
  • 6.11.4 Boehringer Ingelheim GmbH Products Offered
  • 6.11.5 Boehringer Ingelheim GmbH Recent Development
• 6.12 Bayer
  • 6.12.1 Bayer Corporation Information
  • 6.12.2 Bayer Active Pharmaceutical Ingredient Description, Business Overview
  • 6.12.3 Bayer Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
  • 6.12.4 Bayer Products Offered
  • 6.12.5 Bayer Recent Development
• 6.13 BASF
  • 6.13.1 BASF Corporation Information
  • 6.13.2 BASF Active Pharmaceutical Ingredient Description, Business Overview
  • 6.13.3 BASF Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
  • 6.13.4 BASF Products Offered
  • 6.13.5 BASF Recent Development
• 6.14 DSM
  • 6.14.1 DSM Corporation Information
  • 6.14.2 DSM Active Pharmaceutical Ingredient Description, Business Overview
  • 6.14.3 DSM Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
  • 6.14.4 DSM Products Offered
  • 6.14.5 DSM Recent Development
• 6.15 Zhejiang Medicine
  • 6.15.1 Zhejiang Medicine Corporation Information
  • 6.15.2 Zhejiang Medicine Active Pharmaceutical Ingredient Description, Business Overview
  • 6.15.3 Zhejiang Medicine Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
  • 6.15.4 Zhejiang Medicine Products Offered
  • 6.15.5 Zhejiang Medicine Recent Development
• 6.16 Biocon
  • 6.16.1 Biocon Corporation Information
  • 6.16.2 Biocon Active Pharmaceutical Ingredient Description, Business Overview
  • 6.16.3 Biocon Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
  • 6.16.4 Biocon Products Offered
  • 6.16.5 Biocon Recent Development
• 6.17 Johnson Matthey
  • 6.17.1 Johnson Matthey Corporation Information
  • 6.17.2 Johnson Matthey Active Pharmaceutical Ingredient Description, Business Overview
  • 6.17.3 Johnson Matthey Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
  • 6.17.4 Johnson Matthey Products Offered
  • 6.17.5 Johnson Matthey Recent Development
• 6.18 Hisun Pharmacy
  • 6.18.1 Hisun Pharmacy Corporation Information
  • 6.18.2 Hisun Pharmacy Active Pharmaceutical Ingredient Description, Business Overview
  • 6.18.3 Hisun Pharmacy Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
  • 6.18.4 Hisun Pharmacy Products Offered
  • 6.18.5 Hisun Pharmacy Recent Development
• 6.19 Cambrex
  • 6.19.1 Cambrex Corporation Information
  • 6.19.2 Cambrex Active Pharmaceutical Ingredient Description, Business Overview
  • 6.19.3 Cambrex Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
  • 6.19.4 Cambrex Products Offered
  • 6.19.5 Cambrex Recent Development
• 6.20 Shandong Xinhua Pharmaceutical
  • 6.20.1 Shandong Xinhua Pharmaceutical Corporation Information
  • 6.20.2 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Description, Business Overview
  • 6.20.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
  • 6.20.4 Shandong Xinhua Pharmaceutical Products Offered
  • 6.20.5 Shandong Xinhua Pharmaceutical Recent Development
• 6.21 Lonza group
  • 6.21.1 Lonza group Corporation Information
  • 6.21.2 Lonza group Active Pharmaceutical Ingredient Description, Business Overview
  • 6.21.3 Lonza group Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
  • 6.21.4 Lonza group Products Offered
  • 6.21.5 Lonza group Recent Development
• 6.22 Huahai Pharmaceutical
  • 6.22.1 Huahai Pharmaceutical Corporation Information
  • 6.22.2 Huahai Pharmaceutical Active Pharmaceutical Ingredient Description, Business Overview
  • 6.22.3 Huahai Pharmaceutical Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
  • 6.22.4 Huahai Pharmaceutical Products Offered
  • 6.22.5 Huahai Pharmaceutical Recent Development
• 6.23 Haerbin Pharmaceutical Group
  • 6.23.1 Haerbin Pharmaceutical Group Corporation Information
  • 6.23.2 Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Description, Business Overview
  • 6.23.3 Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
  • 6.23.4 Haerbin Pharmaceutical Group Products Offered
  • 6.23.5 Haerbin Pharmaceutical Group Recent Development
• 6.24 Cipla
  • 6.24.1 Cipla Corporation Information
  • 6.24.2 Cipla Active Pharmaceutical Ingredient Description, Business Overview
  • 6.24.3 Cipla Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
  • 6.24.4 Cipla Products Offered
  • 6.24.5 Cipla Recent Development
• 6.25 Tian Yao
  • 6.25.1 Tian Yao Corporation Information
  • 6.25.2 Tian Yao Active Pharmaceutical Ingredient Description, Business Overview
  • 6.25.3 Tian Yao Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
  • 6.25.4 Tian Yao Products Offered
  • 6.25.5 Tian Yao Recent Development
• 6.26 Lupin
  • 6.26.1 Lupin Corporation Information
  • 6.26.2 Lupin Active Pharmaceutical Ingredient Description, Business Overview
  • 6.26.3 Lupin Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
  • 6.26.4 Lupin Products Offered
  • 6.26.5 Lupin Recent Development
• 6.27 North East Pharmaceutical
  • 6.27.1 North East Pharmaceutical Corporation Information
  • 6.27.2 North East Pharmaceutical Active Pharmaceutical Ingredient Description, Business Overview
  • 6.27.3 North East Pharmaceutical Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
  • 6.27.4 North East Pharmaceutical Products Offered
  • 6.27.5 North East Pharmaceutical Recent Development
• 6.28 Albemarle
  • 6.28.1 Albemarle Corporation Information
  • 6.28.2 Albemarle Active Pharmaceutical Ingredient Description, Business Overview
  • 6.28.3 Albemarle Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
  • 6.28.4 Albemarle Products Offered
  • 6.28.5 Albemarle Recent Development
• 6.29 Shandong Lukang Pharmaceutical
  • 6.29.1 Shandong Lukang Pharmaceutical Corporation Information
  • 6.29.2 Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Description, Business Overview
  • 6.29.3 Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
  • 6.29.4 Shandong Lukang Pharmaceutical Products Offered
  • 6.29.5 Shandong Lukang Pharmaceutical Recent Development
• 6.30 Jiangsu Hengrui Medicine
  • 6.30.1 Jiangsu Hengrui Medicine Corporation Information
  • 6.30.2 Jiangsu Hengrui Medicine Active Pharmaceutical Ingredient Description, Business Overview
  • 6.30.3 Jiangsu Hengrui Medicine Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
  • 6.30.4 Jiangsu Hengrui Medicine Products Offered
  • 6.30.5 Jiangsu Hengrui Medicine Recent Development

7 Active Pharmaceutical Ingredient Manufacturing Cost Analysis

• 7.1 Active Pharmaceutical Ingredient Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Raw Materials Price Trend
  • 7.1.3 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredient
• 7.4 Active Pharmaceutical Ingredient Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Active Pharmaceutical Ingredient Distributors List
• 8.3 Active Pharmaceutical Ingredient Customers

9 Market Dynamics

• 9.1 Market Trends
• 9.2 Opportunities and Drivers
• 9.3 Challenges
• 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

• 10.1 Global Active Pharmaceutical Ingredient Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Active Pharmaceutical Ingredient by Type (2021-2026)
  • 10.1.2 Global Forecasted Revenue of Active Pharmaceutical Ingredient by Type (2021-2026)
• 10.2 Active Pharmaceutical Ingredient Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Active Pharmaceutical Ingredient by Application (2021-2026)
  • 10.2.2 Global Forecasted Revenue of Active Pharmaceutical Ingredient by Application (2021-2026)
• 10.3 Active Pharmaceutical Ingredient Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Active Pharmaceutical Ingredient by Region (2021-2026)
  • 10.3.2 Global Forecasted Revenue of Active Pharmaceutical Ingredient by Region (2021-2026)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List